Page 3 - மாநாடு அழைப்பு திட்டமிடப்பட்ட News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conference Call Information ACCESSWIRE Conference Call Scheduled for Tuesday, June 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 14, 2021 / Elite Pharmaceuticals, Inc. ( Elite or the Company )(OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended March 31, 2021 ( Fiscal 2021 ). Consolidated revenues for Fiscal 2021 were $25.4 million, an increase of $7.4 million or approximately 41% from the comparable period of the prior fiscal year. The increase in revenues was primarily attributed to revenues from generic immediate-release Adderall®, generic extended-release Adderall®, generic Dantrolene Capsules, and strong revenues relating to Isradipine sales capsules. Operating profits were $2.1 million, an increase of $4.3 million from the comparable period of the prior year, and net income was $5.1

Exchange commissionLannett companyEpic pharmaPharmaceuticals incGlenmark pharmaceuticals incConference call scheduledElite pharmaceuticalsDantrolene capsulesFiscal yearGlenmark pharmaceuticalsPrivate securities litigation reform actInvestor relationsபரிமாற்றம் தரகுலானெட் நிறுவனம்காவியம் பார்மாமருந்துகள் இன்க்